# A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects

> **NCT06671470** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Haiyan Pharmaceutical Technology Co., Ltd.** · enrollment: 27 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** YZJ-1139 tablets
- **DRUG:** Ticagrelor Tablets

## Key facts

- **NCT ID:** NCT06671470
- **Lead sponsor:** Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-22
- **Primary completion:** 2024-09-13
- **Final completion:** 2024-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671470, "A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06671470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*